Least square mean calculation for the fully replicate design [General Sta­tis­tics]

posted by Jaimik Patel – India, 2019-10-31 11:19 (1022 d 09:35 ago) – Posting: # 20737
Views: 4,207

Dear All,

One question for the least square mean calculation for the fully replicate design as per USFDA in SAS.

We performed the statistical analysis using the code provided in progesterone guideline and Least square mean values of AUCi parameter for the Test and Reference are 6.112006 and 6.111151 respectively.

Unfortunately, after statistical analysis, one error was identified by sponsor in bio-analysis of sample in test formulation. Only one value in particular time point of one period in one subject got changed. Hence, Statistical analysis performed again and it was observed that Least square mean values of AUCi for Test and Reference are 6.111382 and 6.110883. The change in the value of test product results in the change in LSM value in reference product!!

The question is, reference product data remain the same, there is not a single value change in reference data then why Least square mean value of reference product changed AUCi parameter. Why this is affecting the reference data? :confused:

I have also perform the same experiments in two way study design but in that if I am changing any reference data it is not impacting on least square test data.

Please share your thoughts … :-)

Thanks !!
Jaimik


Edit: Category changed; see also this post #1[Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
22,305 posts in 4,668 threads, 1,587 registered users;
online 3 (0 registered, 3 guests [including 1 identified bots]).
Forum time: Thursday 21:55 CEST (Europe/Vienna)

On two occasions I have been asked,—“Pray, Mr. Babbage,
if you put into the machine wrong figures,…
will the right answers come out?”
 …
I am not able rightly to apprehend the kind of confusion of ideas
that could provoke such a question.    Charles Babbage

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5